Inhibitory effects of ulinastatin on tumor cell induced angiogenesis

Dokkyo Journal of Medical Sciences

Volumn 32, Issue 1, 2005, Pages 47-56

  Yoshii, Naoko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Angiogenesis inhibitor; Apoptosis; Metastasis; Ulinastatin

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD31 ANTIGEN; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; ULINASTATIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL DEATH; INHIBITION KINETICS; LUNG METASTASIS; MOUSE; NICK END LABELING; NONHUMAN; SUBCUTANEOUS TISSUE; TAIL; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH;

EID: 20444368080     PISSN: 03855023     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Aiello LP, Avery RL, Arrigg PG, et al: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med., 331: 1480-1487, 1994.
2. Paleolog EM and Miotla JM: Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target. Angiogenesis, 2: 295-307, 1998.
3. O'Reilly MS, Holmgren L, Shing Y, et al: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 72: 315-328, 1994.
4. O'Reilly MS, Boehm T, Shing Y, et al: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
5. Yoon WH, Jung YJ, Kim TD, et al: Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis. Clin. Cancer Res., 10: 4517-4526, 2004.
6. O'Reilly MS, Shepherd SP, Lane WS, et al: Antiangiogenic Activity of the Cleaved Conformation of the Serpin Antithrombin. Science, 285: 1926-1928, 1999.
7. Kobayashi H, Shinohara H, Takeuchi K, et al: Inhibition of the Soluble and the Tumor Cell Receptor-bound Plasmin by Urinary Trypsin Inhibitor and Subsequent Effects on Tumor Cell Invasion and Metastasis. Cancer Res., 54: 844-849, 1994.
8. Kobayashi H, Shinohara H, Fujie M, et al: Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models. Int. J. Cancer, 63: 455-462, 1995.
9. Oikawa T, Sasaki M, Inose M, et al: Effect of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo. Anticancer Res., 17: 1881-1886, 1997.
10. Zhou Z, Christofidou - Solomidou M, Garlanda C, et al: Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice. Angiogenesis, 3: 181-188, 1999.
11. Yano S, Nokihara H, Yamamoto A, et al: Multifunctional interleukin-1 β promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion-and angiogenesis-related molecules. Cancer Sci., 94: 244-252, 2003.
12. Folkman J: Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285: 1182-1186, 1971.
13. 3. Clin. Cancer Res., 6: 3056-3061, 2000.
14. Hurwitz H: Integrating the Anti-VEGF-A Humanized Monoclonal Antibody Bevacizumab with Chemotherapy in Advanced Colorectal Cancer. Clin. Colorectal Cancer, 4: 62-68, 2004.
15. Connolly DT, Heuvelman DM, Nelson R, et al: Tumor Vascular Permeability Factor Stimulates Endothelial Cell Growth and Angiogenesis. J. Clin. Invest., 84: 1470-1478, 1989.
16. 3 Integrins in Tumor Growth, Angiogenesis, and Metastasis. Cancer Res., 62: 2824-2833, 2002.
17. Lakka SS, Gondi CS, Yanamandra N, et al: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene, 23: 4681-4689, 2004.
18. Mazar AP, Henkin J and Goldfarb RH: The urokinase plasminogen activator system in cancer: Implications for tumor angiogenesis and metastasis. Angiogenesis, 3: 15-32, 1999.
19. Larsson H, Sjöblom T, Dixelius J, et al: Antiangiogenic Effects of Latent Antithrombin through Perturbed Cell-Matrix interactions and Apoptosis of Endothelial Cells. Cancer Res., 60: 6723-6729, 2000.
20. Zetter BR: Angiogenesis and tumor metastasis. Annu. Rev. Med., 49: 407-424, 1998.
21. Yoshino S, Kato M and Okada K: Evaluation of the prognostic significance of microvessel count and tumor size in renal cell carcinoma. Int. J. Urol., 5: 119-123, 1998.
22. Pettmann B and Henderson CE: Neuronal cell death. Neuron, 20: 633-647, 1998.
23. Gardner AM, Xu FH, Fady C, et al: Apoptotic vs. non-apoptotic cytotoxicity induced by hydrogen peroxide. Free Radic. Biol. Med., 22: 73-83, 1997
24. Albrecht H, Tschopp J and Jongeneel CV: Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF- κB by TNF. FEBS Lett., 351: 45-48, 1994.
25. Fidler IJ and Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
26. Xu Y, Liu YJ and Yu Q: Angiopoietin-3 Inhibits Pulmonary Metastasis by Inhibiting Tumor Angiogenesis. Cancer Res., 64: 6119-6126, 2004.
27. Xuan JW, Tuck AB, Wilson SM, et al: MMP-2 expression is associated with, but not sufficient for, malignant conversion of murine LTA cells. Anticancer Res., 18: 743-749, 1998.
28. Kobayashi H, Suzuku M, Hirashima Y, et al: The Protease Inhibitor Bikunin, a Novel Anti-Metastatic Agent. Biol. Chem., 384: 749-754, 2003.